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Background and purpose   Metal ion toxicity both locally and 
systemically following MoM hip replacements remains a concern. 
Cobalt ions have been shown to induce secretion of proinflam-
matory chemokines locally; however, little is known about their 
effect systemically. We investigated the in vitro effect of cobalt 
ions on a variety of cell lines by measuring production of the pro-
inflammatory chemokines IL-8 and MCP-1.
Method   Renal, gastrointestinal, and respiratory epithelium 
and also neutrophils and monocytes were exposed to cobalt ions 
at 4, 12, 24, and 48 hours. 
Results We found that cobalt ions enhanced the secretion of IL-8 
and MCP-1 in renal epithelial cells, gastric and colon epithelium, 
monocytes and neutrophils, and small airway epithelial cells but 
not in alveolar cells. Secretion of IL-8 and MCP-1 was markedly 
elevated in renal epithelium, where a 16-fold and 7-fold increase 
occurred compared to controls. There was a 6-fold and 4-fold 
increase in IL-8 and MCP-1 secretion in colon epithelium and 
a 4-fold and 3-fold increase in gastric epithelium. Small airway 
epithelial cells showed a maximum increase in secretion of 8-fold 
(IL-8) and of 4-fold (MCP-1). The increase in chemokine secretion 
observed in alveolar cells was moderate and did not reach statisti-
cal significance. Monocytes and neutrophils showed a 2.5-fold and 
2-fold increase in IL-8 secretion and a 6-fold and 4-fold increase in 
MCP-1 secretion at 48 and 24 hours, respectively. 
Interpretation   These data demonstrate the potent bioactivity 
of cobalt ions in a variety of cell types and the potential to induce 
a proinflammatory response. 
 
In an attempt to reduce polyethylene-induced osteolysis and 
improve implant longevity, there has been renewed interest in 
the use of metal-on-metal (MoM) arthroplasty. The improved 
wear  performance  profiles  result  in  substantially  less  wear 
debris and subsequent periprosthetic osteolysis (Glant et al. 
1993, Shanbhag et al. 1995, Yao et al. 1995). As a result, many 
MoM implants have been shown to last over 2 decades, or 
are still functioning in patients who received the implant at a 
young age (Schmalzried et al. 1996). MoM bearings are now 
commonly used in younger patients where implant longev-
ity is particularly important (Haynes et al. 1993). However, 
metal ion toxicity—both locally in the periprosthetic space 
and systemically—remains a concern (Horowitz et al. 1996, 
Haynes et al. 1997, Fritz et al. 2005, 2006). It has been well 
established that substantial levels of metallic products can be 
transferred into the host environment from implanted metal-
lic devices (Coleman et al. 1973, Merritt and Brown 1993). 
Cobalt-chrome-molybdenum is the alloy used for MoM bear-
ings, due to its wear performance profile. Cobalt and chro-
mium ions are produced as a result of the MoM articulation 
(Cobb et al. 2006). In this study, we have focused on the effect 
of cobalt ions, as we have previously demonstrated a greater 
level of toxicity of these ions compared to chromium ions 
when in contact with primary human osteoblasts (Queally and 
Devitt et al. 2009). 
Local  effects  of  cobalt  ions  in  the  periprosthetic  tissue 
include cytotoxicity, and these ions have been demonstrated 
to induce apoptosis, necrosis, and chemokine secretion (inter-
leukin-8  (IL-8)  and  monocyte  chemoattractant  protein-1 
(MCP-1)) and tumor necrosis factor-α secretion in both mac-
rophages and osteoblasts (Merrit et al. 1993, Catelas et al. 
2001, 2003, 2005, Huk et al. 2004, MacDonald 2004, Petit et 
al. 2004, Fleury et al. 2006, Keegan et al. 2007, Queally and 
Devitt et al. 2009). In comparison, the systemic effect of metal 
ions is relatively unknown. Cobalt ions can be generated in the 
periprosthetic space due to electrochemical corrosion of metal 
particles or possibly as a result of phagocytosis of CoCrMo 
particles by cells and exposure of these particles to a series of 
oxidative mechanisms designed to destroy the foreign body 
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then bind to serum proteins (mainly albumin) and are trans-
ported systemically before being excreted in the urine (Catelas 
et al. 2001, Willert et al. 2005, Rasquinha et al. 2006, Grubl et 
al. 2007). �levated serum levels of cobalt ions have been dem- . �levated serum levels of cobalt ions have been dem-
onstrated, but the clinical implications of this have not been 
fully elucidated yet (Catelas et al. 2003, Petit et al. 2004). 
The  cells  chosen  for  our  experiments  are  representative 
of 3 main organ systems that can be susceptible to chronic 
inflammation: renal, gastrointestinal, and respiratory. Cobalt 
ions are excreted through the renal and gastrointestinal sys-
tems (Cobb and Schmalzreid 2006). In the distal tubule of the 
kidney, proximal tubule epithelial cells are in direct contact 
with cobalt ions during excretion. The gastrointestinal epi-
thelial cells are avascular but are in intimate contact with the 
gastric submucosa and colon submucosa, which possess arte-
rial and venus plexuses that supply and drain the vessels of 
the mucosa, respectively. The diffuse blood supply within this 
layer enables the passage of ions to the mucosa. The respi-
ratory system was also investigated, as previous studies have 
shown an increased incidence of asthma and inflammatory 
conditions following occupational exposure to cobalt (Nemery 
1990). The respiratory system can be divided into two major 
parts, a conducting portion and a respiratory portion. For the 
purpose of our experiments, two varieties of cells representa-
tive of each portion were chosen.
Neutrophils and monocytes represent the first line of defense 
against acute inflammatory processes. As the cobalt ions are in 
intimate contact with these constituents of blood during their 
transit through the vascular system, we also wanted to examine 
the effect that these ions have on monocytes and neutrophils. 
The aim of our study was to investigate the in vitro effect 
of cobalt ions on a variety of human cell lines representing 
potential  systemic  targets  of  cobalt  ion  toxicity.  The  pri-
mary aim was to examine the inflammatory response elicited 
by cobalt ions when exposed to these cells. To achieve this, 
we examined IL-8 and MCP-1, two immediate-early stress 
response chemokines that function to attract neutrophils and 
monocytes respectively. These chemokines initiate the pro-
gression of an inflammatory response, which is governed to 
a large extent by the continued availability of infiltrating leu-
kocytes that are recruited to the site of inflammatory injury. 
Previous studies have shown that cobalt ions lead to increased 
chemokine secretion in primary human osteoblasts with the 
potential to induce osteolysis by recruiting inflammatory leu-
kocytes (Queally and Devitt et al. 2009). We hypothesized that 
cobalt ions have a similar pro-inflammatory effect on other 
systemic cell lines, thus potentially inducing an inflamma-
tory condition or exacerbate an existing one. Specifically, we 
investigated the production of proinflammatory chemokines 
(IL-8 and MCP-1) by these cell types in response to cobalt 
ion exposure.
Materials and methods
Cell culture and metal ion exposure (Table 1)
A  variety  of  cell  lines  were  chosen  to  represent  different 
organ systems. The cells were cultured as monolayers in their 
respective recommended media, in 6-well plates. All experi-
ments were carried out once the cells had reached 80–90% 
confluence and at their optimal passage number. The cells 
were stimulated with 10 parts per million (ppm) cobalt ions 
(Co²+) (CoCl2; Sigma-Aldrich) in growth medium (Table 1). 
This concentration has been used in vitro by other authors in 
assessing the effect of cobalt ions on macrophages (Catelas et 
al. 2001, 2005, Petit et al. 2004, Huk et al. 2004, Fleury et al. 
2006). �ach experiment was carried out in triplicate. Superna-
tants were collected at 4, 12, 24, and 48 h. The medium alone 
without Co2+ was used as a negative control for each cell line. 
Epithelial cells of the renal proximal tubule
Human  Kidney-2  (HK-2)  (American  Type  Culture  Collec-
tion (ATCC) CRL-2190) cells are an immortalized proximal 
tubule epithelial cell line derived from normal adult kidney, 
thus providing an ideal means to assess the mechanism of 
proximal tubule cell physiology and pathophysiology (Ryan 
et al. 1994).
Epithelial cells of the gastrointestinal tract
The in vitro cells used to represent gastric epithelium were the 
AGS cell line (ATCC CRL-1739), which is derived from gas-
tric adenocarcinoma (Barranco et al. 1983). In addition, T84 
cells derived from colonic carcinoma were used. These cells 
have been found to show very similar physiological character-
istics to those of normal colon epithelium, both morphologi-
cally and functionally (Dharmsathaphorn et al. 1984). 
Epithelial cells of the respiratory tract
Two kinds of cells were used, each one representative of each 
portion of the respiratory tract: human small airway epithelial 
cells (representing the conducting portion) and alveolar epi-
thelial cells (representing the respiratory portion). 
Table 1. Cell cultures and culture medium used 
Cell type  Medium  Passage no.
HK-2  DMEM/F12 (1:1), EGF, 10% FBS  12
AGS  Ham’s F12, L-glutamine, 10% FBS  18
T-84  DMEM/F12 (1:1), L-glutamine, 10% FBS  24
SAE  Small Airway Medium with 
  bullet kit (CC-3118, Cambrex, UK)  8
A-549  DMEM, 10% FBS  12
Neutrophils  RPMI medium 1640, 10% FBS  1
Monocytes  RPMI medium 1640, 10% FBS  1
DMEM: Dulbecco’s modified Eagles medium; F12: nutrient mixture; 
EGF: epidermal growth factor; FBS: fetal bovine serum; 
RPMI: Roswell Park Memorial Institute.758  Acta Orthopaedica 2010; 81 (6): 756–764
Human small airway epithelial cells (ScienCell 3230) are 
located at the interface between the alveoli and the conduct-
ing airways. Airway epithelial cells, which form a continu-
ous lining of the airways, have a unique role as a protective 
physical and functional barrier to deleterious external agents. 
These cells are ideal cultures for experimental applications in 
asthma, inhalation toxicology, and pulmonary inflammatory 
responses (Crapo et al. 1983). 
A549 cells (ATCC CCL-185) are human alveolar basal epi-
thelial cells. A549 cells fall under the squamous subdivision 
of epithelial cells, which are associated with the diffusion of 
water, electrolytes, and other substances. The cell line was 
derived from a lung carcinoma established from an explanted 
lung tumor (Giard et al. 1973). 
Human neutrophils and monocytes
Circulating neutrophils and monocytes were extracted from 
the whole blood of healthy donors by Histopaque density cen-
trifugation as previously described (Boyum 1968). Whereas 
monocytes were stimulated with cobalt ions (10 ppm) at time 
points up to 48 h, neutrophils were only exposed for up to 24 
h due to their shorter half-life. 
Preparation and analysis of secreted protein
�nzyme-linked  immunosorbent  assays  (�LISAs)  for  the 
detection of “free” IL-8 and MCP-1 were carried out on the 
supernatant samples according to the manufacturer’s protocol 
(Promocell).
Statistics
For studies on chemokine response, the data shown are from 
1 of 3 experiments, all of which yielded similar results. For 
any given experiment, each data point represents the mean + 
SD of 6 individual cultures. Data were analyzed by one-way 
ANOVA using Analyze-it software. Only p-values ≤ 0.05 were 
considered significant.
Results
The results of chemokine secretion by the different cell lines 
in response to treatment with cobalt ions are summarized in 
Table 2.
Cobalt ions stimulated IL-8 and MCP-1 secretion in 
renal epithelial cells
Following 12, 24, and 48 h of treatment with cobalt ions (at 10 
ppm), renal tubular epithelial cells showed enhanced secretion 
of both IL-8 and MCP-1 relative to the control sample (p < 
0.001) (Figure 1). A 16-fold maximal increase was observed 
for IL-8 secretion, whereas the maximal increase for MCP-1 
secretion was 7-fold.
Cobalt ions stimulated secretion of IL-8 and MCP-1 
in gastrointestinal epithelial cells
Following treatment with cobalt ions (10 ppm), gastric epithe-
lial cells showed enhanced secretion of both IL-8 and MCP-1 
relative to the control sample (p < 0.001) (Figure 2). A 4-fold 
maximal increase was observed for IL-8 secretion and a 3-fold 
maximal increase was observed for MCP-1 secretion. A similar 
increase in chemokine secretion was observed in colon epithe-
lial cells. Following 24 and 48 h of treatment with cobalt ions 
(10 ppm), colon epithelial cells showed enhanced secretion of 
both IL-8 and MCP-1 relative to the control sample (p < 0.001) 
(Figure 3). A 6-fold maximal increase was observed for IL-8, 
whereas the maximal increase in MCP-1 secretion was 4-fold. 
Cobalt ions stimulated secretion of IL-8 and MCP-1 
in small airway epithelial cells but not in alveolar 
epithelial cells
Following 24 and 48 h of treatment with cobalt ions (10 ppm), 
maximal increases of 8- and 4-fold were observed in the secre-
tion of IL-8 and MCP-1, respectively, by small airway epi-
thelial cells (p < 0.001) (Figure 4). An increase in chemokine 
secretion  was  observed  in  alveolar  epithelial  cells  but  this 
increase was not statistically significant (p = 0.06) (Figure 5, 
supplementary data). 
Table 2. Apprixomate fold increase in chemokine secretion relative to contrtol levels
    Length of exposure of cell cultures
  4 hours  12 hours  24 hours  48 hours
Cell type  IL-8  MCP-1  IL-8  MCP-1  IL-8  MCP-1  IL-8  MCP-1 
Renal epithelium  2  0  14 a  5 a  16 a  7 a  15 a  7 a
Gastric epithelium  2  1.2  2.5  2.5 a  3.7 a  3 a  4 a  3 a
Colonic epithelium  1.8  0  1.8  0  4 a  3.3 a  6 a  4 a
SAE  2.5  1.3  3  1.5  5 a  4 a  8 a  4 a
Alveolar epithelium  1.5  0  2  0  2  0  2  2
Neutrophils  0  2.5 a  2 a  4 a  2 a  4 a  N/A  N/A
Monocytes  1.5  1.6  2 a  3  2.5 a  4  2.5 a  6
a p < 0.05
SAE: small airway epithelium; N/A: no available timpe point.   Acta Orthopaedica 2010; 81 (6): 756–764  759
Cobalt ions stimulated secretion of IL-8 and MCP-1 
in neutrophils and monocytes
Following treatment with cobalt ions (10 ppm), neutrophils 
showed enhanced secretion of both IL-8 and MCP-1 relative to 
the control sample (p < 0.001) (Figure 6, supplementary data). 
A 2-fold maximal increase was observed for IL-8 whereas the 
maximal increase in MCP-1 secretion was 4-fold. A similar 
increase in chemokine secretion was observed in monocytes. 
Following  treatment  with  cobalt  ions  (10  ppm),  monocytes 
showed enhanced secretion of both IL-8 and MCP-1 relative to 
the control sample (p < 0.001) (Figure 7, supplementary data). 
A 2.5-fold maximal increase was observed for IL-8 whereas 
the maximal increase in MCP-1 secretion was 6-fold. 
Discussion
Metal-on-metal articulations consist of a cobalt-chromium-
molybdenum alloy and are known to release wear particles 
and  corrosion  products  into  the  periprosthetic  tissue;  they 
are also transported from the joint and distributed systemi-
cally (Coleman et al. 1973, Urban et al. 2000, Jacobs et al. 
2004). There is a measurable increase in cobalt ion levels in 
the serum, erythrocytes, and urine of patients with MoM bear-
ings (Coleman et al. 1973, Jacobs et al. 1998, Savarion et al. 
2002, Brodner et al. 2003, MacDonald et al. 2003, Rasquinha 
et al. 2006). 
The potential effects of elevated levels of metal ions are 
poorly  defined. A  number  of  adverse  biological  reactions 
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Figure 1. Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human renal tubular epithelial cells (HK-2) at 12, 
24 and 48 h. Renal tubule epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a 
significant increase in the secretion of IL-8 protein post exposure at 12, 24 and 48 h relative to the control sample (a = p < 0.001). B: There is also 
a significant increase in the secretion of MCP-1 protein at 12 , 24, and 48h compared to negative control (a = p < 0.001).
  A
  A
  B
  B
Figure 2. Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human gastric epithelial cells (AGS). Gastric epithelial 
cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion 
of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p < 0.001). B: There is also a significant increase in the secretion of 
MCP-1 protein at 12 , 24, and 48h compared to negative control (a = p < 0.001).
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have been linked to the dissemination of metal ions, includ-
ing soft tissue toxicity, hypersensitivity reactions, bone loss, 
and risk of carcinogenesis (Gillespie et al. 1996, Shimmin 
et al. 2005, Willert et al. 2005, Keegan et al. 2007, Lidgren 
2008). In vitro studies have clearly demonstrated that cobalt 
particles  can  be  highly  cytotoxic  when  produced  in  high 
enough concentrations (Merritt and Brown 1993). There is 
also much concern about the effect of long-term exposure and 
the potential for chromosomal aberrations in the patient, as 
well as the risk of passing chromosomal abnormalities to the 
next generation (Case et al. 1996, Doherty et al. 2001, Ladon 
et al. 2004, Bordner et al. 2004a, Papageorgiou et al. 2007, 
Ziaee et al. 2007). 
The inflammatory response to a foreign material is of partic-
ular relevance. This is the area on which we have focused our 
research. The response to a foreign material involves a cascade 
of events. The typical inflammatory response is marked by the 
accumulation of polymorphonuclear leukocytes at the implant 
site. We have previously demonstrated that osteoblasts play an 
integral role in the initiation of this process by secreting pro-
inflammatory chemotactic cytokines, which are sufficient to 
induce the migration of monocytes and neutrophils (Queally 
and Devitt et al. 2009). However, metal ions are not restricted 
to the periprosthetic space and they have direct access to other 
tissues as result of their movement through the blood. In this 
study, we have investigated the specific chemokine responses 
Figure 3. Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human colonic epithelial cells (T-84). Colonic epithe-
lial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion 
of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p < 0.001). B: There is also a significant increase in the secretion of 
MCP-1 protein at 24 and 48h compared to negative control (a = p < 0.001).
Figure 4. Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human small airway epithelial cells. Human small 
airway epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase 
in the secretion of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p < 0.001). B: There is also a significant increase in 
the secretion of MCP-1 protein at 12, 24 and 48h compared to negative control (a = p < 0.001).
0
50
100
150
200
250
300
350
Control 4 12 24 48
Hours of exposure
IL-8 (pg/mL) – colonic epithelial cells – 10 ppm cobalt ions
a
a
0
50
100
150
200
250
300
350
400
450
Control 4 12 24 48
Hours of exposure
MCP-1 (pg/mL) – colonic epithelial cells – 10 ppm cobalt ions
a
a
0
50
100
150
200
250
300
Control 4 12 24 48
Hours of exposure
IL-8 (pg/mL) – small airway epithelial cells – 10 ppm cobalt ions
a
a
0
50
100
150
200
250
300
350
400
450
500
Control 4 12 24 48
Hours of exposure
MCP-1 (pg/mL) – small airway epithelial cells – 10 ppm cobalt ions
a
a
  A
  A
  B
  BActa Orthopaedica 2010; 81 (6): 756–764  761
in a variety of human cell lines that represent potential systemic 
targets of cobalt ion toxicity, following exposure to cobalt ions 
(Firriolo et al. 1999, Urban et al. 2000, IARC Monographs) 
Chemokines are the major mediators of chemotactic signaling 
in the recruitment and activation of inflammatory cells (Miller 
et al. 1992, Taub et al. 1994). IL-8 and MCP-1 are immediate-
early stress response chemokines that function to attract neu-
trophils and monocytes, respectively. 
Unlike most organic chemicals, metals cannot be eliminated 
from tissues by metabolic degradation. Thus, they can only be 
eliminated from tissues by renal or gastrointestinal excretion 
(Cobb and Schmalzreid 2006). It is widely regarded, although 
without evidence-based research, that MoM bearing surfaces 
are contraindicated in patients with chronic renal failure. In 
such cases, there is a potential for elevated cobalt levels within 
the circulation as a result of reduced excretion (Brodner et al. 
2000). However, of equal concern is the effect that cobalt ions 
have on renal tissue and whether this effect contributes to 
renal failure in itself. In light of this, we explored the effect of 
exposure of proximal tubule epithelial cells to cobalt ions. In 
this study, we have demonstrated for the first time that cobalt 
ions enhance protein secretion of IL-8 and MCP-1 in renal 
proximal tubule epithelial cells. The enhanced secretion was 
substantial, representing a 16-fold and 7-fold increase, respec-
tively, compared to control levels. 
Proinflammatory mediators recruit neutrophils and mono-
cytes  to  the  site  of  insult,  which  drive  the  inflammatory 
response. In the setting of chronic renal failure, the added 
insult of a further inflammatory stimulus may be sufficient to 
tip the balance into a vicious circle of reduced excretion and 
increased circulating levels of cobalt ions. The effect may also 
be compounded by the fact that neutrophils and monocytes, 
having been recruited, also give rise to enhanced IL-8 and 
MCP-1 secretion following exposure to cobalt ions (10 ppm). 
Whether this is sufficient to induce full renal failure remains 
to be seen, but it is certainly an area of concern and warrants 
further research.
Urban et al. have previously demonstrated the dissemination 
of wear particles to the liver, spleen, and abdominal lymph 
nodes of patients with a hip or knee replacement following 
retrieval studies (Urban et al. 2000). The gastrointestinal tract 
is intimately related to these three routes of dissemination, 
via the portal venous system and lymphatic drainage (Stran-
dring 2008). In the present study, elevated secretion of these 
proinflammatory chemokines was seen in gastric and colon 
epithelium.  Gastric  epithelium  showed  a  4-fold  and  3-fold 
maximal enhanced secretion of IL-8 and MCP-1, respectively, 
while colon epithelium showed a maximal 6-fold increase in 
IL-8 secretion and a 4-fold increase in MCP-1 secretion. It 
is difficult to assess the importance of this enhanced secre-
tion from gastrointestinal epithelium. A link may perhaps be 
drawn  between  this  and  another  chronic  relapsing  inflam-
matory condition that can occur in the gastrointestinal tract, 
inflammatory  bowel  disease.  This  disease  is  characterized 
by continuous infiltration of affected tissue by inflammatory 
cells from the circulation. This influx results in further tissue-
destructive inflammatory processes. The recruitment and acti-
vation of immunocytes is mediated by chemokines, including 
IL-8 and MCP-1 (Uguccioni et al. 1999, McCormack et al. 
2001). Chemokine secretion is low or non-existent in resting 
cells but rapidly becomes upregulated during inflammation 
(Luster  1998).  The  potential  therefore  exists  for  quiescent 
inflammatory bowel disease to become reactivated as a result 
of an inflammatory insult, thus perpetuating the disease pro-
cess (McCormack et al. 2001). Is it then possible that exposure 
to high levels of cobalt ions in an individual with inflamma-
tory bowel disease may precipitate a relapse of the inflamma-
tory condition. This is simply a theory, and to date there have 
been no case reports to corroborate this. It is certainly some-
thing to consider in a young patient with inflammatory bowel 
disease requiring a total hip replacement, perhaps as a result 
of steroid-induced avascular necrosis of the hip (Klingenstein 
et al. 2005).
Frequent  contact  with  inhaled  cobalt  from  occupational 
exposure  has  been  shown  to  cause  an  increased  incidence 
of asthma and chronic inflammatory pulmonary conditions, 
either from the particles themselves or from solubilized cobalt 
ions (Nemery 1990, IARC Monographs). The toxic responses 
of the respiratory system in metal workers are largely related 
to inhalation exposure, and are therefore difficult to extrapo-
late to the vascular route. The respiratory system can be differ-
entiated into two major parts: a conducting portion, consisting 
of structures that deliver air to the lungs, and a respiratory por-
tion, consisting of structures within the lungs where oxygen 
is exchanged for carbon dioxide in the blood. The respiratory 
system has lining epithelia, supporting structures, glands, and 
other features that are characteristic of each part. The blood 
flow to the intraparenchymal airways is predominately from 
the bronchial circulation (Bernard et al. 1996). As a result, 
cobalt ions bound to proteins have the potential to come in 
contact with respiratory epithelium through systemic trans-
mission. Our experiments demonstrate that exposure of small 
airway epithelial cells to cobalt ions can give rise to an 8-fold 
increase in IL-8 secretion and a 4-fold increase in MCP-1 
secretion. Regarding human alveolar epithelial cells, roughly 
a 2-fold (maximal) increase in both IL-8 and MCP-1 secretion 
was observed, but this did not reach statistical significance. 
These results suggest that the conduction portion of the respi-
ratory  system  induces  an  inflammatory  response  following 
exposure to cobalt ions while the respiratory portion remains 
relatively quiescent. Once again, the significance of these data 
in the clinical setting is unknown and to date there have been 
no case reports documenting any deterioration in chronic pul-
monary conditions following MoM hip replacement. Further 
work is required to determine the long-term implications of 
elevated cobalt ion levels in patients with pulmonary disease.
Finally, we explored the effect of exposure of monocytes 
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We found that monocytes have a rapid response to cobalt ions, 
inducing the secretion of IL-8 and MCP-1 at 4, 12, 24, and 
48 h. Likewise, neutrophils showed a significant increase in 
secretion of these cytokines. These cells are found both in the 
circulation and deposited in tissues. They appear to have dual 
roles as responders to inflammation and recruiters of further 
leukocytes once stimulated by cobalt ions, thereby perpetuat-
ing the inflammatory cascade.
Metallic debris may exist as particles, in ionic form, or as 
inorganic salts. In this study, we used cobalt ions at a con-
centration of 10 ppm. The exact concentration of these ions 
in the periprosthetic space and systemically remains unclear, 
as there has been variation in study design, in the sources of 
samples (serum, whole blood, erythrocytes, and urine), and 
in the method of laboratory analysis (Catelas et al. 2005). 
This concentration has been used in vitro by other authors in 
assessing the effect of cobalt ions on macrophages (Catelas 
et al. 2001, 2005, Huk et al. 2004, Petit et al. 2004, Fleury et 
al. 2006). Serum blood levels are less than 10 ppm; however, 
these higher levels may be seen in patients with “runaway” 
wear (see below) or in the setting of renal failure (Hur et al. 
2008, Lee et al. 2008). There is recent evidence to suggest that 
cobalt levels are influenced by factors such as the type, design, 
and positioning of the implant (Savarino et al. 2002, Brodner 
et al. 2003, Back et al. 2005a). The position of the implant, 
which is influenced by the skill of the surgeon, plays a major 
role in the degree of metal ion release. Brodner reported a 10- 
to 53-fold increase in cobalt levels in patients with an ace-
tabular cup inclination of between 58° and 63° (Brodner et 
al. 2004b). The classical “run-in” period is well recognized 
with MoM prostheses, as peak serum levels of cobalt show 
a 10-fold increase at six months relative to the preoperative 
levels (Back et al. 2005b, Daniel et al. 2007). These peaks 
are followed by a gradual decline over the next 15 months 
as the bearing surface enters “steady-state” wear. Bowsher 
et al. (2009) have also described the concept of “runaway” 
wear, which is a puzzling phenomenon that can result in a 2- to 
19-fold increase in wear in prostheses compared to identical 
bearings (Bowsher et al. 2009). 
In summary, the data presented here demonstrate the potent 
bioactivity of cobalt ions in a variety of systemic cell lines. 
This process is most likely representative of an overall toxic 
effect of high-dose exposure to cobalt ions. The significance 
of these findings has particular relevance in the context of 
patients undergoing hip replacement surgery with pre-existing 
renal failure, where there is a greater degree of exposure to 
high levels of cobalt ions due to reduced excretion. It may also 
be important in cases where the hip implant cup inclination 
is placed in excessive abduction or where “runaway” wear is 
experienced. In addition, due consideration should be given 
to the choice of bearing surface in patients with inflammatory 
bowel disease due to the possibility of triggering a relapse.
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analysis. JSB: cell culture. DM: study design. PPD: chief scientific supervi-
sor. JMO’B: senior author.
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